Strowd Re

44PUBLICATIONS
133CO-AUTHORS
Haematological tumoursMining, energy and natural resources lawCancer therapy (excl. chemotherapy and radiation therapy)Inclusive educationMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Dec 01, 2025
STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma.

Howard Colman, Giuseppe Lombardi, Eric T Wong

|Oct 29, 2025
Leukocyte-intrinsic ER stress responses contribute to chemotherapy-induced peripheral neuropathy.

Miriam M Fonseca, Oriana Gelblung, Sarah D Pennypacker

|Feb 19, 2025
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma.

Veronica Rendo, Eudocia Q Lee, Connor Bossi

Pageof 8